AVRO
NASDAQAVROBIO Inc.
Latest news
25 items- 13D/GSEC Form SC 13D filed by AVROBIO Inc.SC 13D - Tectonic Therapeutic, Inc. (0001681087) (Subject)
- SECAVROBIO Inc. filed SEC Form 8-K: Regulation FD Disclosure8-K - Tectonic Therapeutic, Inc. (0001681087) (Filer)
- 13D/GSEC Form SC 13D filed by AVROBIO Inc.SC 13D - Tectonic Therapeutic, Inc. (0001681087) (Subject)
- INSIDERFormer 10% owner of AVROBIO Leonard Braden Michael acquired 433,688 shares (SEC Form 4)4 - Tectonic Therapeutic, Inc. (0001681087) (Issuer)
- INSIDERSEC Form 4 filed by Director Donenberg Phillip B.4 - Tectonic Therapeutic, Inc. (0001681087) (Issuer)
- INSIDERDirector Vitorovic Stefan was granted 1,028,674 shares (SEC Form 4)4 - Tectonic Therapeutic, Inc. (0001681087) (Issuer)
- INSIDERSEC Form 3 filed by new insider Vitorovic Stefan3 - Tectonic Therapeutic, Inc. (0001681087) (Issuer)
- INSIDERDirector Tipirneni Praveen P. was granted 3,037 shares (SEC Form 4)4 - Tectonic Therapeutic, Inc. (0001681087) (Issuer)
- INSIDERSEC Form 3 filed by new insider Tipirneni Praveen P.3 - Tectonic Therapeutic, Inc. (0001681087) (Issuer)
- INSIDERDirector Springer Timothy A was granted 4,243,121 shares (SEC Form 4)4 - Tectonic Therapeutic, Inc. (0001681087) (Issuer)
- INSIDERSEC Form 3 filed by new insider Springer Timothy A3 - Tectonic Therapeutic, Inc. (0001681087) (Issuer)
- INSIDERDirector Mcguire Terrance was granted 1,157,976 shares (SEC Form 4)4 - Tectonic Therapeutic, Inc. (0001681087) (Issuer)
- INSIDERSEC Form 3 filed by new insider Mcguire Terrance3 - Tectonic Therapeutic, Inc. (0001681087) (Issuer)
- INSIDERSEC Form 4 filed by Chief Business Officer Schwabish Marc4 - Tectonic Therapeutic, Inc. (0001681087) (Issuer)
- INSIDERSEC Form 3 filed by new insider Schwabish Marc3 - Tectonic Therapeutic, Inc. (0001681087) (Issuer)
- INSIDERChief Medical Officer Ruddy Marcella K. was granted 32,065 shares (SEC Form 4)4 - Tectonic Therapeutic, Inc. (0001681087) (Issuer)
- INSIDERSEC Form 3 filed by new insider Ruddy Marcella K.3 - Tectonic Therapeutic, Inc. (0001681087) (Issuer)
- INSIDERChief Scientific Officer Mcnamara Peter was granted 10,688 shares (SEC Form 4)4 - Tectonic Therapeutic, Inc. (0001681087) (Issuer)
- INSIDERSEC Form 3 filed by new insider Mcnamara Peter3 - Tectonic Therapeutic, Inc. (0001681087) (Issuer)
- INSIDERSEC Form 4 filed by Chief Financial Officer Lochner Daniel4 - Tectonic Therapeutic, Inc. (0001681087) (Issuer)
- INSIDERSEC Form 3 filed by new insider Lochner Daniel3 - Tectonic Therapeutic, Inc. (0001681087) (Issuer)
- INSIDERChief Operating Officer Cortis Christian was granted 126,368 shares (SEC Form 4)4 - Tectonic Therapeutic, Inc. (0001681087) (Issuer)
- INSIDERSEC Form 3 filed by new insider Cortis Christian3 - Tectonic Therapeutic, Inc. (0001681087) (Issuer)
- INSIDERChief Executive Officer Reicin Alise was granted 291,110 shares (SEC Form 4)4 - Tectonic Therapeutic, Inc. (0001681087) (Issuer)
- INSIDERSEC Form 3 filed by new insider Reicin Alise3 - Tectonic Therapeutic, Inc. (0001681087) (Issuer)
AVRO FAQ
7 questionsWhat does AVROBIO Inc. do?
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the target disease. The company's lead product candidate is AVR-RD-01, a gene therapy which is in ongoing company-sponsored Phase 2 clinical trial and investigator-sponsored Phase 1 clinical trial for the treatment of Fabry disease. It is also developing...Where does AVRO stock trade?
AVROBIO Inc. (AVRO) is listed on NASDAQ.What sector and industry is AVRO in?
AVROBIO Inc. operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.When did AVROBIO Inc. go public?
AVROBIO Inc. (AVRO) completed its IPO in 2018.What are analysts saying about AVRO?
AVROBIO Inc. has had 8 recent analyst actions on file. The most recent action was from Mizuho: Neutral on 2023-12-18.What companies are similar to AVRO?
Notable peers in the same industry include AMGN (Amgen Inc.), GILD (Gilead Sciences Inc.), ARGX (argenx SE), RVMD (Revolution Medicines Inc.), BIIB (Biogen Inc.). Compare AVRO side-by-side with any of them on Quantisnow.How can I track AVRO on Quantisnow?
Quantisnow aggregates AVROBIO Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow AVRO to receive live email and push alerts on every new disclosure.